FCGR2B and autoimmune hemolytic anemia: Notably, splenic macrophages also express FcγRIIb, an inhibitory receptor whose activation may underlie the limited efficacy of intravenous immunoglobulin (IVIG) therapy in AIHA, as IVIG is thought to exert its effects, at least in part, through interactions with FcγRIIb (12).